Open AccessOsteoprotegerin Lys3Asn Polymorphism and the Risk of Fracture in Older Women
Author(s) -
Susan P Moffett,
Jennifer Oakley,
Jane A. Cauley,
Li Lui,
Kristine E. Ensrud,
Brent C Taylor,
Teresa A. Hillier,
Marc C. Hochberg,
J. Li,
Shelia Cayabyab,
J. M. Lee,
Gary Peltz,
Steven R. Cummings,
J. M. Zmuda
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-1019
Subject(s) - medicine , femoral neck , bone mineral , osteoporosis , hip fracture , bone density , osteoprotegerin , confidence interval , endocrinology , gastroenterology , receptor , activator (genetics)
Osteoprotegerin (OPG) is a soluble decoy receptor for receptor activator nuclear factor kappa-beta that blocks osteoclastic bone resorption.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom